Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Recent advances in nanotechnology have offered a new hope for the oral and systemic delivery of the fragile therapeutic molecules. Nanotechnology has the potential to offer solutions to several of the aforementioned obstacles. The physicochemical characteristics of the materials including polymers, metals, and semiconductors offer distinct advantages for in vivo applications. Altered properties could be increased surface area, optical, electronic, magnetic and structural properties as well as quantum effects dictated by the nanometer scale that are not available from individual molecules or bulk solids. Properties such as self-assembly, stability, specificity drug encapsulation and imaging contrast of the nanoparticles have already been used clinically to provide targeted cellular/tissue delivery of chemotherapeutics, to improve drug bioavailability, to sustain drug effect in target tissue and to diagnose disease.
Source: Cancer Nanotechnology
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi